dihexa fda approval Peptide Therapy DIHEXA - Beverly Hills Rejuvenation
DIHEXA Beverly Hills Rejuvenation Center Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted The Peptide Craze Ground Truths FDA Peptide Reclassification 2026 Amanecia Health
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25


